Try our Advanced Search for more refined results

Harden Manufacturing Corporation v. Pfizer, Inc. et al

Track this case

Case Number:

1:04-cv-10981

Court:

Nature of Suit:

Other Statutory Actions

Multi Party Litigation:

Class Action

Judge:

Firms

Companies

Sectors & Industries:

May 15, 2009
3rd Parties Again Denied Class Cert. In Neurontin Suit

Fearing a “tsunami” of trials, a judge has denied a renewed request to certify a class of third-party payers in a suit against Pfizer Inc. and Warner-Lambert Co. over alleged promotion of the epilepsy drug Neurontin for off-label uses such as restless legs syndrome.
October 08, 2008
Pfizer Accused Of Manipulating Epilepsy Drug Data

Plaintiffs seeking class action status in a multidistrict litigation against Pfizer Inc. have submitted documents allegedly showing that the drug giant's employees suppressed negative information about the epilepsy drug Neurontin.
August 29, 2008
Pfizer Seeks Emergency Sanctions In Neurontin Suit

Defendants Pfizer Inc. and Warner-Lambert Co. have asked a federal judge to grant emergency sanctions against a number of plaintiffs for their alleged failure to obey a court order to respond to defendants' interrogatories in a consolidated class action about epilepsy drug Neurontin.
June 20, 2008
Pfizer Ignored Neurontin Suicide Link: Testimony

At a hearing in the consolidated class action against Pfizer Inc. over its epilepsy drug Neurontin, a neurologist has reportedly claimed that Pfizer ignored his recommendation over a decade ago that the drug carry a label warning of possible side effects of depression and aggression.
January 23, 2007
Judge To Consider Class In Pfizer's Neurontin Cases

Nearly three years after criminal charges were settled in Pfizer Inc.’s illegal marketing of the epilepsy drug Neurontin, a federal judge is considering whether or not to grant class action status in nearly 200 consolidated civil lawsuits.

← Previous
1
2
Next →